Survival data of U-LMS based on RNase H2 status and RNASEH2B/RB1 HomDel status A) Overall survival of U-LMS patients based on loss of RNase H2 (n=23) or intact RNase H2 (n=85) by IHC B) Overall survival of ULMS patients with or without RNASEH2B HomDels, based on the presence or absence of RB1 HomDels.
No takes yet. Share an insight, caveat, or question.
Nakazawa et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: